Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Fixed Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.800.811.131.321.16

What is the latest Fixed Capital/Sales ratio of NATCO PHARMA ?

The latest Fixed Capital/Sales ratio of NATCO PHARMA is 0.80 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.80
Mar20240.81
Mar20231.13
Mar20221.32
Mar20211.16

How is Fixed Capital/Sales of NATCO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.8
-1.23
Mar2024 0.81
-28.32
Mar2023 1.13
-14.39
Mar2022 1.32
13.79
Mar2021 1.16 -

Other Financial Ratios of NATCO PHARMA


Compare Fixed Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,730.4 Cr 4.3% 6% -34.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,666.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 2.7% 0.4% 3.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.3%

6%

-34.9%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses